At the same time, KL-6 was proposed as diagnostic marker for fibrotic interstitial lung disease (ILD) and over the years, it demonstrated its usefulness as a marker for predictive prognosis and response to antifibrotic therapy [5,6,7,8,9,10,11,12,13,14]. Here, MUC1 is linked to interstitial lung disease.